AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

aap Implantate AG

Share Issue/Capital Change Mar 16, 2009

10_rns_2009-03-16_4c4c771e-00f4-4f1b-a6e4-d4484c2b5dc0.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 16 March 2009 16:44

aap Implantate AG: Capital Increase as part of the performance-improvement program

aap Implantate AG / Corporate Action

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


The Management Board of aap Implantate AG, a medical technology company
listed on the Frankfurt stock exchange in the Prime Standard segment,
decided today with the Supervisory Board's approval to increase its capital
stock from authorized capital by approx. 5%, or EUR1,267,357. The new
shares are subscribed today, excluding rights entitlement for existing
shareholders, by way of a private placement in return for a cash
contribution at a price of EUR 1.00. The company's capital stock thereby
increases by EUR 1,267,357 from the present EUR 26,614,513 to EUR
27,881,870.

Within a financing commitment of a shareholder of EUR 2 million and the
funds of the above mentioned capital increase, aap obtains a total inflow
of approx. EUR 3.3 million. Alongside, aap was able to accomplish a release
of a shareholder's loan of EUR 0.5 million.

These measures serve the purpose of securing the corporate finance and are
a component of aap's performance-improvement program, which include the
optimization of the capital structure, cost reduction measures, simplifying
the organizational structure, divestiture of non-core business units,
pushing a profitable company growth as well as maintaining the existing
innovation pace.

Contact:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Head of Corporate Communications &
Legal Affairs; Lorenzweg 5; D-12099 Berlin
Tel.: ++49/30/750 19 - 133; Fax.: ++49/30/750 19 - 290; [email protected]

16.03.2009 Financial News transmitted by DGAP

Language: English
Issuer: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: [email protected]
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Hannover, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.